In contrast, the oncogene MYC uORF-encoded peptide MPEP promotes GBM cell growth by activating tropomyosin receptor kinase B (TRKB) and AKT-mTOR signaling; the overexpression of MPEP is related to the poor prognosis of GBM patients [134]. This evidence concerns the gene NTRK2 and glioblastoma.